Endocrine Journal
Online ISSN : 1348-4540
Print ISSN : 0918-8959
ISSN-L : 0918-8959
ORIGINAL
Successful diagnosis and treatment of pheochromocytoma during severe coronavirus disease 2019 (COVID-19): a case report
Yasutaka TsujimotoMasaaki Yamamoto Seiji NishikageKeitaro KanieMaki KanzawaHironori BandoKei YoshinoYushi HirotaHidenori FukuokaWataru Ogawa
Author information
JOURNAL FREE ACCESS FULL-TEXT HTML

2023 Volume 70 Issue 3 Pages 259-265

Details
Abstract

Pheochromocytoma is a rare but life-threatening condition due to catecholamine release induced by drug treatments such as β-blockers or glucocorticoids. We present a case of hypertensive crisis due to pheochromocytoma, induced after the initiation of dexamethasone and landiolol during intensive care for severe coronavirus disease 2019 (COVID-19). Based on a detailed medical history review, the patient was previously diagnosed with primary aldosteronism by confirmatory tests, moreover, an abdominal computed tomography scan identified an adrenal tumor 2 years before current admission. We tentatively diagnosed the patient with pheochromocytoma and initiated α-blockers without conducting a catecholamine report, leading to stable hemodynamics. We present a successfully managed case of pheochromocytoma concomitant with COVID-19, which has become a global crisis.

Content from these authors
© The Japan Endocrine Society
Previous article Next article
feedback
Top